Status:
UNKNOWN
Carriage Clearance of Emerging Highly Resistant Bacteria in Chronic Dialysis Patients
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Chronic Kidney Diseases
Dialysis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The propias, and more recently the update of the recommendations relating to the control of the spread of bacteria highly resistant to emerging antibiotics issued by the High Council of Public Health ...
Eligibility Criteria
Inclusion
- Adult patient (≥ 18 years old)
- Patient with stage V chronic renal failure, treated by chronic dialysis (hemodialysis or peritoneal dialysis) and monitored at AURA Paris (AURA Paris Plaisance Dialyse and hospitalization, AURA Nord, AURA Corentin Celton, AURA Bichat)
- Patient affiliated to a health insurance plan
- French-speaking patient
- Patient who has given free, informed and written consent
Exclusion
- Patient under guardianship or curatorship
- Patient deprived of liberty
- Patient under legal protection
- Pregnant or breastfeeding woman
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 14 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04699682
Start Date
March 15 2021
End Date
March 14 2025
Last Update
April 14 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
AURA Corentin Celton
Paris, Groupe Hospitalier Paris Saint-Joseph, France, 75014
2
AURA Paris Plaisance
Paris, Groupe Hospitalier Paris Saint-Joseph, France, 75014
3
AURA Paris Site de Saint Ouen
Paris, Groupe Hospitalier Paris Saint-Joseph, France, 75014
4
Groupe Hospitalier Paris Saint-Joseph
Paris, Groupe Hospitalier Paris Saint-Joseph, France, 75014